446 related articles for article (PubMed ID: 11408215)
1. MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa.
Mao W; Warren MS; Lee A; Mistry A; Lomovskaya O
Antimicrob Agents Chemother; 2001 Jul; 45(7):2001-7. PubMed ID: 11408215
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of MexXY and OpmG in aminoglycoside efflux in Pseudomonas aeruginosa.
Chuanchuen R; Wannaprasat W; Schweizer HP
Southeast Asian J Trop Med Public Health; 2008 Jan; 39(1):115-22. PubMed ID: 18567450
[TBL] [Abstract][Full Text] [Related]
3. Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system.
Poole K; Gilmour C; Farha MA; Parkins MD; Klinoski R; Brown ED
J Antimicrob Chemother; 2018 May; 73(5):1247-1255. PubMed ID: 29420743
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa.
Hocquet D; Nordmann P; El Garch F; Cabanne L; Plésiat P
Antimicrob Agents Chemother; 2006 Apr; 50(4):1347-51. PubMed ID: 16569851
[TBL] [Abstract][Full Text] [Related]
5. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
Hocquet D; Muller A; Blanc K; Plésiat P; Talon D; Monnet DL; Bertrand X
Antimicrob Agents Chemother; 2008 Mar; 52(3):1173-5. PubMed ID: 18180356
[TBL] [Abstract][Full Text] [Related]
6. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability.
Buyck JM; Plésiat P; Traore H; Vanderbist F; Tulkens PM; Van Bambeke F
Clin Infect Dis; 2012 Aug; 55(4):534-42. PubMed ID: 22573850
[TBL] [Abstract][Full Text] [Related]
7. Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis.
Chuanchuen R; Wannaprasat W; Ajariyakhajorn K; Schweizer HP
Microbiol Immunol; 2008 Aug; 52(8):392-8. PubMed ID: 18667038
[TBL] [Abstract][Full Text] [Related]
8. Aminoglycoside resistance in
Thacharodi A; Lamont IL
J Med Microbiol; 2022 Jun; 71(6):. PubMed ID: 35708991
[No Abstract] [Full Text] [Related]
9. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.
Dean CR; Visalli MA; Projan SJ; Sum PE; Bradford PA
Antimicrob Agents Chemother; 2003 Mar; 47(3):972-8. PubMed ID: 12604529
[TBL] [Abstract][Full Text] [Related]
10. MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides.
Hocquet D; Vogne C; El Garch F; Vejux A; Gotoh N; Lee A; Lomovskaya O; Plésiat P
Antimicrob Agents Chemother; 2003 Apr; 47(4):1371-5. PubMed ID: 12654672
[TBL] [Abstract][Full Text] [Related]
11. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin.
Hocquet D; Roussel-Delvallez M; Cavallo JD; Plésiat P
Antimicrob Agents Chemother; 2007 Apr; 51(4):1582-3. PubMed ID: 17220417
[No Abstract] [Full Text] [Related]
12. Polymyxin Susceptibility in Pseudomonas aeruginosa Linked to the MexXY-OprM Multidrug Efflux System.
Poole K; Lau CH; Gilmour C; Hao Y; Lam JS
Antimicrob Agents Chemother; 2015 Dec; 59(12):7276-89. PubMed ID: 26369970
[TBL] [Abstract][Full Text] [Related]
13. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides.
Aires JR; Köhler T; Nikaido H; Plésiat P
Antimicrob Agents Chemother; 1999 Nov; 43(11):2624-8. PubMed ID: 10543738
[TBL] [Abstract][Full Text] [Related]
14. MexXY RND pump of
Singh M; Sykes EME; Li Y; Kumar A
Microbiology (Reading); 2020 Nov; 166(11):1095-1106. PubMed ID: 32909933
[TBL] [Abstract][Full Text] [Related]
15. Knock-out of multidrug efflux pump MexXY-OprM results in increased susceptibility to antimicrobial peptides in Pseudomonas aeruginosa.
Neidig A; Strempel N; Waeber NB; Nizer WSDC; Overhage J
Microbiol Immunol; 2023 Sep; 67(9):422-427. PubMed ID: 37424105
[TBL] [Abstract][Full Text] [Related]
16. Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7.
Morita Y; Tomida J; Kawamura Y
Microbiology (Reading); 2012 Apr; 158(Pt 4):1071-1083. PubMed ID: 22282519
[TBL] [Abstract][Full Text] [Related]
17. Role of MexAB-OprM and MexXY-OprM efflux pumps and class 1 integrons in resistance to antibiotics in burn and Intensive Care Unit isolates of Pseudomonas aeruginosa.
Goli HR; Nahaei MR; Rezaee MA; Hasani A; Kafil HS; Aghazadeh M; Nikbakht M; Khalili Y
J Infect Public Health; 2018; 11(3):364-372. PubMed ID: 28993173
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the OprM outer membrane component of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa.
Li XZ; Poole K
J Bacteriol; 2001 Jan; 183(1):12-27. PubMed ID: 11114896
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa.
Masuda N; Sakagawa E; Ohya S; Gotoh N; Tsujimoto H; Nishino T
Antimicrob Agents Chemother; 2000 Sep; 44(9):2242-6. PubMed ID: 10952562
[TBL] [Abstract][Full Text] [Related]
20. Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa.
Hirakata Y; Kondo A; Hoshino K; Yano H; Arai K; Hirotani A; Kunishima H; Yamamoto N; Hatta M; Kitagawa M; Kohno S; Kaku M
Int J Antimicrob Agents; 2009 Oct; 34(4):343-6. PubMed ID: 19615866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
